DSC Advisors’s Eli Lilly LLY Stock Holding History

DSC Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-939	Closed	-$304K	–	56
2022 Q3	$304K	Sell	939 -433	-32%	-$137K	0.31%	63
2022 Q2	$445K	Sell	1,372 -59	-4%	-$17.7K	0.44%	40
2022 Q1	$410K	Buy	+1,431	New	+$368K	0.14%	66

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DSC Advisors's LLY Position: Q4 2022 in Review

DSC Advisors sold out of Eli Lilly (LLY) in Q4 2022, closing a stake of 939 shares — an estimated $304K sold.

DSC Advisors first reported a position in LLY in Q1 2022 and held it in 3 quarters. The position peaked at $445K in Q2 2022. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

DSC Advisors reported no remaining Eli Lilly position as of Q4 2022 after selling out during the quarter.
DSC Advisors sold 939 Eli Lilly shares in Q4 2022, an estimated $304K.
DSC Advisors first reported a position in Eli Lilly in Q1 2022 and held it in 3 quarters.
DSC Advisors's Eli Lilly position peaked at $445K in Q2 2022.
2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on DSC Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.